Tag: Contract Manufacturing

Mayne Pharma opened an oral solid-dose commercial manufacturing facility

Mayne Pharma Group, a branded and generic pharmaceuticals company, opened new $80-million, oral solid-dose commercial manufacturing facility in Greenville, North Carolina, USA.

3P Biopharmaceuticals signed a contract manufacturing agreement with Intervacc

3P Biopharmaceuticals, a Spanish biotechnology company, and the Swedish company Intervacc completed negotiations and signed the agreement for contract manufacturing of Strangvac®.

Rentschler Biopharma and Leukocare reported about effective cooperation

Rentschler Biopharma SE, a leading contract development and manufacturing organization, and Leukocare AG, a biotechnology company, reported on the successful first year of their unique strategic alliance.

Samsung Biologics signed the first contract for its newly built Plant 3

samsung biologics
Samsung BioLogics entered into the first manufacturing contract for its Plant 3 facility. The approximate value of the contract is $148 million if the product will be successful in the clinic.

Richard Král was appointed as a new CEO of Saneca Pharma CDMO

Richard, who has been the sales and marketing director at Saneca for almost three years, has previously worked for GlaxoSmithKline and Zentiva Group.

South Korean SK Biotek opens a manufacturing campus in Ireland

SK Biotek has confirmed that it plans to operate and develop Swords Campus as a stand-alone CDMO, which will manufacture pharma products to specification for other pharmaceutical companies on a contract basis

CDMO KBI Biopharma strengthens its positions

KBI Biopharma, Inc., a biopharmaceutical Contract Development & Manufacturing Organization, has completed the acquisition of the assets of Elion Labs , a leading contract services organization

Russian State Duma has approved draft law on developing the contract manufacturing

At its plenary session held on January 19, the deputies of the State Duma adopted at the first reading the draft law “On Amendments to the Federal law “On circulation of medicines”

Wuxi Griffin will give effect to Western GMP standards in its operation

pharmaceutical manufacturing
The new company, Wuxi Griffin, is to operate as an international contract manufacturer of sterile fill pharmaceuticals. It is a western managed joint venture between Sweden and China

TxCell accomplished CAR-Treg manufacturing process development

gene therapy
TxCell SA announced it has completed the development of its first-generation production process for its proprietary CAR-Treg technology

Nativa starts manufacturing multi-dose powder inhalers

In 2018 Nativa will launch the manufacturing of multi-dose powder inhalers for the treatment of bronchopulmonary diseases

Authorities decide to simplify the entry of foreign drugs to the Russian market

Russian Ministry of Industry and Trade has prepared the draft law “On Amendments to the Federal Law On Circulation of Medicines”

Contract pharmaceutical manufacturing sites in Russia are very relevant

contract manufacturing
A round table on Contract Manufacturing of Pharmaceutical Products was held on November 22, 2017, at Pharmtech & Ingredients 2017

New dedicated biopharma event launches alongside CPhI Worldwide 2018 in Madrid

CPhI Worldwide
New event to create unique synergies between the parallel worlds of large, small molecules and contract services

Sotex launches Russian-made medicines onto European market

The production facility of Sotex, which is the core of the PROTEK Group manufacturing segment, received the European GMP certificate

CDMO Pfizer CentreOne opens new manufacturing facility in Japan

Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, announced that it is now offering services in Nagoya, Japan